Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
72.70
+1.21 (1.69%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 204.6 | 183.64 | 94.82 | 224.95 | 71.66 | 171.33 |
Short-Term Investments | 245.1 | 233.63 | 196.56 | 2.5 | 145.37 | 0.48 |
Cash & Short-Term Investments | 449.69 | 417.27 | 291.38 | 227.44 | 217.03 | 171.82 |
Cash Growth | 17.98% | 43.21% | 28.11% | 4.80% | 26.31% | 2.19% |
Accounts Receivable | 96.03 | 85.06 | 46.76 | 16.62 | - | - |
Other Receivables | 2.28 | 2.05 | 1.3 | 1.09 | 3.58 | 0.09 |
Receivables | 98.31 | 87.11 | 48.06 | 17.71 | 3.58 | 0.09 |
Inventory | 4.38 | 4.37 | 2.62 | 3.11 | - | - |
Prepaid Expenses | 9.61 | 13.47 | 14.65 | 7.87 | 4.77 | 4.05 |
Restricted Cash | - | 0.56 | - | - | - | - |
Total Current Assets | 561.99 | 522.78 | 356.71 | 256.13 | 225.38 | 175.95 |
Property, Plant & Equipment | 30.4 | 21.75 | 2.87 | 3.35 | 1.53 | 1.83 |
Long-Term Investments | 6.68 | 3.87 | 3 | 0.86 | 0.48 | 0.66 |
Other Intangible Assets | 6.89 | 7.37 | 8.33 | 3.87 | - | - |
Other Long-Term Assets | 5.19 | 6.4 | 6.09 | 1.29 | 0.48 | 0.46 |
Total Assets | 611.14 | 562.16 | 376.99 | 265.49 | 227.86 | 178.91 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 40.14 | 16.39 | 9.42 | 17.77 | 5.5 | 2.86 |
Accrued Expenses | 46.55 | 26.88 | 19.14 | 13.9 | 9.21 | 7.26 |
Current Portion of Leases | 0.15 | - | 0.61 | 0.4 | 0.72 | 0.61 |
Current Income Taxes Payable | 2.11 | 1.81 | - | - | - | 0.06 |
Current Unearned Revenue | - | - | - | - | - | 0.7 |
Other Current Liabilities | 86.8 | 90.62 | 51.44 | 4.87 | - | - |
Total Current Liabilities | 175.75 | 135.7 | 80.61 | 36.94 | 15.43 | 11.48 |
Long-Term Debt | 72.76 | 72.44 | 71.85 | 29.82 | 19.43 | - |
Long-Term Leases | 15.9 | 10.6 | - | - | - | 0.59 |
Other Long-Term Liabilities | - | - | - | 1.75 | 0.1 | 0.11 |
Total Liabilities | 264.41 | 218.73 | 152.46 | 68.5 | 34.96 | 12.18 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
Additional Paid-In Capital | 799.43 | 769.67 | 584.56 | 441.64 | 301.73 | 213.4 |
Retained Earnings | -452.15 | -426.63 | -360.21 | -244.66 | -108.76 | -46.67 |
Comprehensive Income & Other | -0.56 | 0.38 | 0.18 | -0 | -0.07 | - |
Total Common Equity | 346.73 | 343.43 | 224.53 | 196.99 | 192.9 | 166.73 |
Shareholders' Equity | 346.73 | 343.43 | 224.53 | 196.99 | 192.9 | 166.73 |
Total Liabilities & Equity | 611.14 | 562.16 | 376.99 | 265.49 | 227.86 | 178.91 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 88.81 | 83.04 | 72.45 | 30.22 | 20.16 | 1.19 |
Net Cash (Debt) | 360.88 | 334.23 | 218.92 | 197.23 | 196.87 | 170.62 |
Net Cash Growth | 16.90% | 52.67% | 11.00% | 0.18% | 15.38% | 1.99% |
Net Cash Per Share | 8.40 | 8.00 | 5.82 | 6.71 | 8.00 | 8.30 |
Filing Date Shares Outstanding | 43.88 | 42.56 | 38.38 | 34.22 | 26.73 | 20.71 |
Total Common Shares Outstanding | 43.27 | 42.55 | 38.35 | 34.21 | 26.73 | 20.7 |
Working Capital | 386.24 | 387.09 | 276.09 | 219.2 | 209.95 | 164.47 |
Book Value Per Share | 8.01 | 8.07 | 5.85 | 5.76 | 7.22 | 8.06 |
Tangible Book Value | 339.85 | 336.06 | 216.21 | 193.12 | 192.9 | 166.73 |
Tangible Book Value Per Share | 7.85 | 7.90 | 5.64 | 5.64 | 7.22 | 8.06 |
Machinery | 6.52 | 3.84 | 3.5 | 2.08 | 1.08 | 0.85 |
Leasehold Improvements | 15.82 | 9.93 | 0.79 | 0.68 | 0.43 | 0.13 |